BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32305443)

  • 1. United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.
    Zic JA; Ai W; Akilov OE; Carter JB; Duvic M; Foss F; Girardi M; Gru AA; Kim E; Musiek A; Olsen EA; Schieke SM; Shinohara M; Zain JM; Geskin LJ
    J Am Acad Dermatol; 2020 Aug; 83(2):703-704. PubMed ID: 32305443
    [No Abstract]   [Full Text] [Related]  

  • 2. A new nail in the CTCL coffin.
    Lessin SR
    J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of primary cutaneous lymphoma patients during COVID-19 pandemic: EORTC CLTF guidelines.
    Papadavid E; Scarisbrick J; Ortiz Romero P; Guaglino P; Vermeer M; Knobler R; Stadler R; Bagot M
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1633-1636. PubMed ID: 32416629
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and Therapy of Primary Cutaneous T-Cell Lymphoma: Collegium Internationale Allergologicum (CIA) Update 2020.
    Bobrowicz M; Fassnacht C; Ignatova D; Chang YT; Dimitriou F; Guenova E
    Int Arch Allergy Immunol; 2020; 181(10):733-745. PubMed ID: 32690848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Cutaneous T-Cell Lymphomas.
    Larocca CA; LeBoeuf NR
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
    Whittaker SJ; Marsden JR; Spittle M; Russell Jones R; ;
    Br J Dermatol; 2003 Dec; 149(6):1095-1107. PubMed ID: 14696593
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).
    Bunn PA; Hoffman SJ; Norris D; Golitz LE; Aeling JL
    Ann Intern Med; 1994 Oct; 121(8):592-602. PubMed ID: 8085692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome.
    Baron MK; Osborn JD; Tao R; Lee CJ
    Leuk Lymphoma; 2020 Jan; 61(1):231-233. PubMed ID: 31452419
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy for Cutaneous T-Cell Lymphoma: Current Landscape and Future Developments.
    Sivanand A; Surmanowicz P; Alhusayen R; Hull P; Litvinov IV; Zhou Y; Gniadecki R
    J Cutan Med Surg; 2019; 23(5):537-544. PubMed ID: 31353944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib.
    Foss FM; Rubinowitz A; Landry ML; Isufi I; Gowda L; Seropian S; Perreault S; Shenoi SV
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):720-723. PubMed ID: 32727701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
    Duvic M; Chiao N; Talpur R
    J Cutan Med Surg; 2003; 7(4 Suppl):3-7. PubMed ID: 12958700
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy of cutaneous lymphoma--current practice and future developments.
    Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
    Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
    Bunn PA
    Arch Dermatol; 1995 May; 131(5):603-5. PubMed ID: 7537952
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?
    Chu C; Sun Y; Pan Y
    Oral Oncol; 2020 Aug; 107():104860. PubMed ID: 32571643
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2016 Jan; 91(1):151-65. PubMed ID: 26607183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2017 Oct; 92(10):1085-1102. PubMed ID: 28872191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.